Vancouver, British Columbia – October 21, 2025 – (CSE:PNGA) (OTC:PNGAF) (“Pangea” or the “Company”) is pleased to announce that its wholly owned subsidiary, Amino Innovations Inc. (“Amino Innovations”), has created a new peptide patch technology designed to simplify advanced peptide delivery, making it as easy as applying a bandage. This new platform aims to revolutionize daily wellness through precise, needle-free administration.
The Amino Innovations Patch employs bio-dissolving lattice technology to efficiently deliver peptides through the skin’s surface layers for rapid and effective absorption, without requiring pain, mixing, or needles. Its proprietary design achieves one-to-one dosing equivalence with traditional injectable methods, removing the need for reconstitution, sterile handling, and dose measurement. Amino Innovations’ Patches are compact, suitable for air travel, stable for up to six months on the shelf, and ensure consistent peptide delivery for active individuals, travelers, and longevity enthusiasts seeking enhanced recovery and wellness support.
Developed in the United States and produced in a cGMP-certified facility, each patch undergoes stringent third-party testing to guarantee pharmaceutical-grade purity, stability, and consistency. By combining scientific precision with user-friendliness, Amino Innovations has developed a clean, compliant, and accessible peptide solution for consumers looking to optimize their performance and recovery without the challenges associated with injections.
The Company’s initial launch will feature two formulations aimed at boosting recovery and immune optimization. The first formulation, known as the “Wolverine Stack Patch,” combines BPC-157 and Thymosin Beta 4 (TB4), two naturally occurring peptides recognized for their role in supporting healing, muscle recovery, tissue regeneration, and overall physical resilience. Alongside this, Amino Innovations plans to introduce the TA-1 patch, formulated to help promote immune balance and strengthen the body’s natural defense systems.
Mr. Justin Kirkland, CSO and Co-Founder of Amino Innovations, remarked, “These new formulations represent a significant advancement in our mission to make sophisticated peptide science both accessible and effortless. We are dedicated to bringing innovation, integrity, and accessibility to a category that is rapidly moving from niche to mainstream. These patches are designed to empower individuals to enhance recovery, cellular health, and overall vitality in a simple, convenient, and needle-free format.”
The development of Amino Innovations’ peptide patch platform marks a significant milestone in its ongoing expansion into the health and wellness sector. The Company remains committed to introducing inventive, evidence-based products that align with its vision of providing pure and effective wellness solutions for contemporary consumers.
“The creation of this patch technology and its subsequent validation through a third-party study could potentially lead to a breakthrough in peptide delivery and significantly expand the total addressable market size in North America and globally. We anticipate providing further updates during Q4-2025,” stated Mr. Pratap Sandhu, CEO of Pangea.
About Pangea Natural Foods Inc.
Pangea Natural Foods Inc. is a North American manufacturer specializing in clean-label food products and innovative wellness solutions. Through its subsidiary Amino Innovations, the Company offers advanced, needle-free peptide therapies that support recovery, cognitive function, and overall health.
On Behalf of the Board of Directors
“Pratap Sandhu”
Pratap Sandhu
CEO, Corporate Secretary and Director
+1 (604) 765-8069
Forward-Looking Information
This news release contains forward-looking statements and forward-looking information as defined by applicable securities laws. These statements pertain to future events or future performance. All statements other than those of historical fact may constitute forward-looking statements or information. The forward-looking statements and information are based on certain key expectations and assumptions made by the Company’s management, including Amino Innovation’s commercialization of the peptide patches. Consequently, there can be no guarantee that the acquisition or related matters will be completed as proposed or at all. While the Company’s management believes that the expectations and assumptions underlying such forward-looking statements and information are reasonable, undue reliance should not be placed on them, as there is no assurance they will prove to be accurate.